Analytic Investors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Analytic Investors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-59,495	Closed	-$2.45M	–	684
2016 Q1	$2.45M	Buy	59,495 +11,624	+24%	+$479K	0.03%	281
2015 Q4	$2.32M	Buy	47,871 +4,677	+11%	+$208K	0.03%	272
2015 Q3	$1.73M	Buy	43,194 +21,878	+103%	+$956K	0.02%	304
2015 Q2	$855K	Sell	21,316 -685	-3%	-$23.6K	0.01%	398
2015 Q1	$720K	Buy	+22,001	New	+$608K	0.01%	406

Other funds holding SYNH

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Analytic Investors's SYNH Position: Q2 2016 in Review

Analytic Investors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2016, closing a stake of 59,495 shares — an estimated $2.45M sold.

Analytic Investors first reported a position in SYNH in Q1 2015 and held it in 5 quarters. The position peaked at $2.45M in Q1 2016. 209 funds tracked by Wall St. Rank hold SYNH as of Q2 2016.

Analytic Investors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2016 after selling out during the quarter.
Analytic Investors sold 59,495 Syneos Health, Inc. Class A Common Stock shares in Q2 2016, an estimated $2.45M.
Analytic Investors first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 5 quarters.
Analytic Investors's Syneos Health, Inc. Class A Common Stock position peaked at $2.45M in Q1 2016.
209 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2016.

Based on Analytic Investors's 13F filing for Q2 2016, filed 11 Aug 2016.